99% Savings - Buy Just @1 Rs X
Sucralfate + Pantoprazole is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Based on research, the following side effects have been observed when Sucralfate + Pantoprazole is used -
Moderate
Mild
Common
Is the use of Sucralfate + Pantoprazole safe for pregnant women?
Sucralfate + Pantoprazole is safe to take during pregnancy.
Is the use of Sucralfate + Pantoprazole safe during breastfeeding?
Sucralfate + Pantoprazole can cause moderate side effects on breastfeeding women. If you feel its side effects, then stop taking this drug and consult your doctor. Take this medicine again only if your doctor advises to do so.
What is the effect of Sucralfate + Pantoprazole on the Kidneys?
Using Sucralfate + Pantoprazole does not have any harmful effects on kidneys.
What is the effect of Sucralfate + Pantoprazole on the Liver?
Sucralfate + Pantoprazole is rarely harmful for the liver.
What is the effect of Sucralfate + Pantoprazole on the Heart?
There are no any side effects of Sucralfate + Pantoprazole for the heart.
Sucralfate + Pantoprazole should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Sucralfate + Pantoprazole unless your doctor advises you to do so -
Is this Sucralfate + Pantoprazole habit forming or addictive?
Sucralfate + Pantoprazole is not addictive in nature.
Interaction between Food and Sucralfate + Pantoprazole
You can take Sucralfate + Pantoprazole with food.
Interaction between Alcohol and Sucralfate + Pantoprazole
Taking alcohol with Sucralfate + Pantoprazole can be dangerous.
Yes, Sucralfate + Pantoprazole might help with IBS (irritable bowel syndrome) but there is insufficient scientific data available for its use in IBS. Since it is a prescription drug you are advised to not take it by yourself.
No, Sucralfate + Pantoprazole does not case black stools. It has not been reported by the patients who are taking this drug. If you are experiencing black stools after taking this drug, then it might be due to some other reason and you are advised to discuss it with your doctor.
Yes, Sucralfate + Pantoprazole can treat gastritis. It is used in the treatment of gastritis because it forms a protective layer in the gastrointestinal lining which helps in providing relief from gastric inflammation.
Yes, Sucralfate + Pantoprazole might be helpful in treating GERD. It helps in GERD by forming a protective layer on the wall of the gastrointestinal tract as well esophagus that protects the symptoms of GERD such as heartburn and acidity.
Take Sucralfate + Pantoprazole 1-2 times in a day or as advised by your doctor. Sucralfate + Pantoprazole should be taken empty stomach,1 hour before a meal or 2 hours after the meal so that it can form a protective coating in the gastrointestinal lining. Precautions must be taken in patients with improper kidney function.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Carafate
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 656-657
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1154-1155
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Protonix (pantoprazole sodium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 653
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 984-986